Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Lina Duo"'
Autor:
Lina Duo, Ting Wu, Ziliang Ke, Linghan Hu, Chaohui Wang, Guigen Teng, Wei Zhang, Weihong Wang, Qing Ge, Yong Yang, Yun Dai
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 22, Iss , Pp 924-936 (2020)
Dysregulated mucosal immunity plays an essential role in the pathophysiology of inflammatory bowel disease (IBD). Transient receptor potential vanilloid 1 (TRPV1) is a Ca2+-permeable ion channel that is implicated in modulating immune responses. Howe
Externí odkaz:
https://doaj.org/article/37ba8889789b485e84b496530f2ee094
Publikováno v:
2022 2nd International Conference on Electronic Information Engineering and Computer Technology (EIECT).
Autor:
Yong Yang, Guigen Teng, Wei Zhang, Ting Wu, Qing Ge, Chaohui Wang, Weihong Wang, Linghan Hu, Yun Dai, Lina Duo, Ziliang Ke
Publikováno v:
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 22, Iss, Pp 924-936 (2020)
Molecular Therapy: Nucleic Acids, Vol 22, Iss, Pp 924-936 (2020)
Dysregulated mucosal immunity plays an essential role in the pathophysiology of inflammatory bowel disease (IBD). Transient receptor potential vanilloid 1 (TRPV1) is a Ca2+-permeable ion channel that is implicated in modulating immune responses. Howe
Publikováno v:
Cancer letters. 527
Transient receptor potential vanilloid 1 (TRPV1) is a Ca
Autor:
Weilong Zhong, Jie Zhang, Li Tang, Xianning Zhang, Xu Cao, Mingyang Lee, Linghan Hu, Xiuli Wang, Jiahui Zhao, Lina Duo, Yong Yang, Quan Chen, Huijun Wang, Cheng Feng, Zhimiao Lin
Publikováno v:
The Journal of investigative dermatology. 141(3)
We have previously shown that gain-of-function variations in transient receptor potential vanilloid-3 (TRPV3) underlay Olmsted syndrome, a rare hyperkeratotic skin channelopathy. In this study, we attempt to establish a genotype‒phenotype correlati
Autor:
Eray Yihui Zhou, Guiwen Xu, Jiahui Zhao, Jinghua Yin, Cheng Feng, Huijun Wang, Lina Duo, Yong Yang, Zhimiao Lin, Zhi-hong Ma
Publikováno v:
The Journal of Dermatology. 44:71-75
Xeroderma pigmentosum (XP) is a rare genetic disorder which is divided into eight complementation groups: XP-A to XP-G and XP-V. Some XP patients demonstrate severe cutaneous and neurological manifestations, management of which requires timely diagno
Publikováno v:
Molecular Pain
Transient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel, which can detect various noxious stimuli that cause pain, inflammation, hyperalgesia, and itch. TRPV1 knock-out mice show deficiency in nociception, but the in vivo e
Autor:
Huijun Wang, Jinghua Yin, Jianguo Zhang, Xu Cao, Lanlan Dai, Liu Xuanzhu, Zhimiao Lin, Lina Duo, Jie Zhang, Jiahui Zhao, Yong Yang, Zhanli Tang
Publikováno v:
Gene. 566:84-88
As a powerful tool to identify the molecular pathogenesis of Mendelian disorders, exome sequencing was used to identify the genetic basis of two siblings with hearing loss and hypotrichosis and clarify the diagnosis. No pathogenic mutations in GJB2,
Autor:
Edel A. O'Toole, Jianguo Zhang, Eray Yihui Zhou, Xun Xu, Lanlan Dai, Mary E. Schwartz, Christian Cole, Vincent Plagnol, Claire A. Scott, Yong Yang, Yali Ren, Daniela Nitoiu, Lina Duo, Neil J. Wilson, Frances J.D. Smith, Yulan Chen, Cheng Feng, Zhimiao Lin, Jiahui Zhao, Huijun Wang, David P. Kelsell, W.H. Irwin McLean
Publikováno v:
The American Journal of Human Genetics. 96(3):440-447
Calpastatin is an endogenous specific inhibitor of calpain, a calcium-dependent cysteine protease. Here we show that loss-of-function mutations in calpastatin (CAST) are the genetic causes of an autosomal-recessive condition characterized by generali
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2018 (2018)
Evidence-Based Complementary and Alternative Medicine, Vol 2018 (2018)
Background.Radiation therapy is an important mode of colorectal cancer treatment. However, most people die of local recurrence after tumors become resistant to radiotherapy, and little progress has been made in treating radiotherapy-resistant colorec